- Report
- January 2022
- 278 Pages
Global
From €3748EUR$4,250USD£3,233GBP
- Report
- January 2022
- 278 Pages
Global
From €3748EUR$4,250USD£3,233GBP
- Report
- January 2022
- 52 Pages
Europe
From €1100EUR$1,336USD£982GBP
- Report
- January 2022
- 60 Pages
Global
From €3484EUR$3,950USD£3,005GBP
- Report
- November 2021
- 159 Pages
Global
From €3748EUR$4,250USD£3,233GBP
- Report
- February 2021
- 35 Pages
Global
€1162EUR$1,318USD£1,003GBP
- Report
- December 2020
- 63 Pages
Germany
From €540EUR$634USD£450GBP
- Report
- December 2020
- 200 Pages
Global
€3925EUR$4,450USD£3,385GBP
- Book
- April 2019
- 836 Pages
Canada
- Report
- February 2019
- 55 Pages
Global
From €1050EUR$1,275USD£937GBP
- Training
- 120 Minutes
Global
- Training
- 60 Minutes
Global
- Drug Pipelines
- January 2022
- 30 Pages
Global
From €441EUR$500USD£380GBP
- Drug Pipelines
- January 2022
- 30 Pages
Global
From €441EUR$500USD£380GBP
- Drug Pipelines
- January 2022
- 30 Pages
Global
From €441EUR$500USD£380GBP
- Drug Pipelines
- January 2022
- 30 Pages
Global
From €441EUR$500USD£380GBP
- Drug Pipelines
- January 2022
- 30 Pages
Global
From €441EUR$500USD£380GBP
- Report
- July 2025
Europe
From €1848EUR$2,095USD£1,594GBP
€3519EUR$3,990USD£3,035GBP
From €1848EUR$2,095USD£1,594GBP
€3519EUR$3,990USD£3,035GBP

The Analgesics market is a sector of the pharmaceutical industry that focuses on the production and sale of drugs used to relieve pain. Analgesics are used to treat a variety of conditions, including headaches, muscle pain, arthritis, and post-operative pain. Common analgesics include non-steroidal anti-inflammatory drugs (NSAIDs), opioids, and acetaminophen.
Analgesics are available in a variety of forms, including tablets, capsules, liquids, and topical creams. Many analgesics are available over-the-counter, while others require a prescription.
The analgesics market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the analgesics market include Pfizer, Johnson & Johnson, GlaxoSmithKline, Novartis, and Merck. Show Less Read more